Thyro-L description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Thyro-L

LLOYD, Inc. of Iowa

Thyro-L


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

Indications

For use in horses for correction of conditions associated with low circulating thyroid hormone (hypothyroidism).

Dosage

The suggested initial dose is 0.5 to 3.0 mg levothyroxine sodium (T-4) per 100 pounds body weight (1 to 6 mg per 100 kg) once per day or in divided doses. Response to the administration of Thyro-L should be evaluated clinically until an adequate maintenance dose is established. In most horses, this is usually in the range of 6 to 36 mg (½ to 3 level teaspoons) total daily dose of T-4. Serum T-3 and T-4 values can vary greatly among individual horses on thyroid supplementation. Dosages should be individualized and animals should be monitored daily for clinical signs of hyperthyroidism or hypersensitivity.

Administration

For oral dosing as directed by a veterinarian.

Warning

Use with caution in animals with clinically significant heart disease, hypertension or other complications for which a sharply increased metabolic rate might prove hazardous. Use in pregnant mares has not been evaluated.

Caution

Federal law restricts this product to use by or on the order of a licensed veterinarian.

Active Ingredient per pound (453.6 g)

Levothyroxine Sodium 0.22% (1,000mg)

One level teaspoonful contains approximately 12 mg of T-4.

One level tablespoonful contains approximately 36 mg of T-4.

Teaspoon measure included.

IMPORTANT
KEEP OUT OF REACH OF CHILDREN

Store at room temperature and protect from light.
Avoid excessive heat (104°F).

Thyro-L

LLOYD, Inc.
Shenandoah, Iowa 51601 U.S.A.

List No. 0481
1004

PRINCIPAL DISPLAY PANEL - 453.6 g Bottle Label

LLOYD

Net wt: One Pound (453.6 g)

Thyro-L ®

Levothyroxine sodium powder, USP
for horses

Thyro-L

Thyro-L

LEVOTHYROXINE SODIUM POWDER

Product Information

Product Type Prescription animal drug label Item Code (Source) NDC:11789-048
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
LEVOTHYROXINE SODIUM LEVOTHYROXINE 1000 mg

Inactive Ingredients

Ingredient Name Strength
DIBASIC CALCIUM PHOSPHATE DIHYDRATE
cellulose, microcrystalline
calcium silicate
ALPHA-TOCOPHEROL ACETATE
ETHOXYQUIN
CALCIUM CARBONATE
Mineral Oil
SODIUM CHLORIDE
LACTOSE
CORN OIL
propylene glycol
BUTYLATED HYDROXYTOLUENE
CITRIC ACID MONOHYDRATE
BUTYLATED HYDROXYANISOLE

Product Characteristics

Color
GRAY (Gray powder)

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:11789-048-10 453.6 in 1 BOTTLE, PLASTIC
2 NDC:11789-048-20 4536 in 1 PAIL

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
1990-06-25


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.